


Liquid Biopsy Labs Email Formats
Biotechnology Research • Canada • 1-10 Employees
Key Contact at Liquid Biopsy Labs
Kimberly Lauren Bryant
Marketing and Media Director
Company overview
| Headquarters | Canada |
| Phone number | +18884052721 |
| Website | |
| SIC | 873 |
| Keywords | Genetic Testing, Precision Medicine, Cancer Research, Cancer Screening, Cfdna, Liquid Biopsy, Precision Oncology, Cancer Diagnosis, Ctdna, Oncogenomics, Clinical Application, Exosome, Cancer Treatment Monitoring, Exosome-Based Liquid Biopsies, Targeted Treatment Recommendations |
| Founded | 2018 |
| Employees | 1-10 |
About Liquid Biopsy Labs
The first liquid biopsy – in the world – to test for an almost INFINITE number of mutations. The only liquid biopsy to provide accurate cancer treatment monitoring. With Liquid Biopsy Labs, every cancer patient can easily have a highly targeted treatment plan. About LBL: Precision oncology should not include guessing or hoping – it should include the most accurate diagnosis possible through medical science today. With Liquid Biopsy Labs’ unique, personalized, and precise testing protocol, you’ll have true confidence in your cancer treatment plan. From start to finish, our testing protocol is designed for certainty. And, we can test for almost any mutation. Most liquid biopsy tests can only effectively be used for discovery. Because of limitations in their design, standard liquid biopsy tests only show if a patient has a mutation in their blood – meaning that, at best, standard liquid biopsy can be used to confirm what has already been identified in any genetic tumor tissue test. In other words, if you choose a targeted treatment based on the results of a standard liquid biopsy test, your ‘targeted’ therapy is actually more like a shot in the dark, or perhaps a ‘best guess’. You might get it right, but you may also be completely wrong. After nine years of researching many different liquid biopsy tests from around the world – and exploring combinations of additional diagnostics – research scientist Alexander Rolland (co-founder of Liquid Biopsy Labs), has designed a test that can confidently be used for both discovery and monitoring how well a treatment is working. Our unique, patent-pending test quantitatively measures the amount of a tumor-causing mutation in the blood. Read more to discover how Liquid Biopsy Labs' revolutionary liquid biopsy test can show if your patient's tumor is growing, slowing, or gone – with 99+% accuracy! www.liquidbiopsylabs.com
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Liquid Biopsy Labs has never raised funding before.
Liquid Biopsy Labs Tech Stack
Discover the technologies and tools that power Liquid Biopsy Labs's digital infrastructure, from frameworks to analytics platforms.
CDN
Web servers
CDN
Security
JavaScript libraries
Tag managers
Font scripts
CDN
Miscellaneous
UI frameworks
Video players
Ecommerce
Frequently asked questions
4.8
40,000 users



